Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

Clinical trial NCT00193596 · COMPLETED

Trial details

NCT number: NCT00193596
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Unknown Primary

Start date: 2003-09-01
Primary completion: 2008-09-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.